INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Lobbying registrant
MP

MARSHALL & POPP, LLC

Open in network
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections13with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • Lobbied forevidence
    VERIZON COMMUNICATIONS INCLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • Lobbied forevidence
    VERTEX PHARMACEUTICALS INC / MALDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    ABBOTT LABORATORIESLDA Q1 2026 first quarter · Agriculture, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    GRAIL, Inc.LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    FORD MOTOR COLDA Q1Y 2026 first quarter · issues not listed · Aug 26, 2026
  • Lobbied forevidence
    GSK plcLDA RR 2026 first quarter · Pharmacy, Trade · Aug 26, 2026
  • Lobbied forevidence
    PFIZER INCLDA Q1 2026 first quarter · Trade, Taxation, Pharmacy, Copyright/patent · Aug 26, 2026
  • Lobbied forevidence
    ELI LILLY & CoLDA Q1 2026 first quarter · Medicare/Medicaid, Pharmacy · Aug 26, 2026
  • Lobbied forevidence
    BRISTOL MYERS SQUIBB COLDA RR 2026 first quarter · Pharmacy, Trade · Aug 26, 2026
  • Lobbied forevidence
    Butterfly Network, Inc.LDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • Lobbied forevidence
    3M COLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • Lobbied forevidence
    AbbVie Inc.LDA Q2 2026 second quarter · Pharmacy · Aug 26, 2026
  • Lobbied forevidence
    BridgeBio Pharma, Inc.LDA Q1 2026 first quarter · Pharmacy · Aug 26, 2026